Arrowhead Pharmaceuticals Inc (ARWR) Common Stock USD0.001
0.05%- This stock can be held in a
Stocks and Shares ISASell:$19.53
Buy:$19.55
Change:
$0.07
(0.36%)
$0.07
(0.36%)Market closed | Prices delayed by at least 15 minutes
Sell:$19.53
Buy:$19.55
Change:$0.07
(0.36%)
$0.07
(0.36%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 23 December 2024 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 12,563 | $19.59 | $246,109.17 | 3,775,772 |
| 18 December 2024 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 12,653 | $20.52 | $259,639.56 | 3,702,394 |
| 18 December 2024 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 8,260 | $21.74 | $179,572.40 | 3,694,134 |
| 18 December 2024 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 5,799 | $22.12 | $128,273.88 | 3,688,335 |
| 17 December 2024 | Douglass Bruce GivenChairman of the Board | Sell Tax related | 547 | $22.04 | $12,055.88 | 124,167 |
| 17 December 2024 | William D WaddillIndependent Director | Sell Tax related | 3,747 | $22.04 | $82,583.88 | 40,378 |
| 16 December 2024 | Douglass Bruce GivenChairman of the Board | Sell Tax related | 5,000 | $21.90 | $109,500.00 | 124,714 |
| 16 December 2024 | William D WaddillIndependent Director | Sell Tax related | 3,748 | $21.90 | $82,081.20 | 44,125 |
| 16 December 2024 | Victoria (Vicki) VakienerIndependent Director | Sell Tax related | 8,994 | $21.91 | $197,058.54 | 21,211 |
| 2 July 2024 | Tracie OliverChief Level Officer | Sell Tax related | 9,394 | $25.28 | $237,480.32 | 127,107 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 6 March 2024 | Kenneth Allen MyszkowskiCFO | Sell Regular sell transaction (market) | 40,000 | $35.19 | $1,407,600.00 | 400,600 |
| 31 January 2024 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 37,769 | $32.16 | $1,214,651.04 | 3,734,778 |
| 31 January 2024 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 19,730 | $32.71 | $645,368.30 | 3,715,048 |
| 5 January 2024 | Patrick O'BrienCOO | Sell Tax related | 12,741 | $35.65 | $454,216.65 | 464,385 |
| 5 January 2024 | James C. HamiltonSenior Vice President | Sell Tax related | 12,343 | $35.65 | $440,027.95 | 228,791 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.